Medicine containing epirubicin, preparation method thereof, pharmaceutical composition and application thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- BAI YAO ZHI DA BEIJING NANOBIO TECH CO LTD
- Publication Date
- 2022-07-22
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The present application relates to the field of medicine, in particular, to a medicine containing epirubicin, its preparation method, pharmaceutical composition and application. Background technique
[0002] Epirubicin (Epirubicin, CSA: 56420-45-2, molecular formula: C 27 H 29 NO 11 .HCI, molecular weight: 580.0) is an anti-tumor antibiotic and an isomer of doxorubicin. Its mechanism of action is to directly intervene between DNA nucleic acid base pairs, interfere with the transcription process, prevent the formation of mRNA, and thereby inhibit DNA , RNA and protein synthesis. It is a cell cycle non-specific drug that is effective against a variety of transplanted tumors, including acute leukemia and malignant lymphoma, breast cancer, bronchial lung cancer, ovarian cancer, Wilms tumor, soft tissue sarcoma, liver cancer (including primary hepatic cell carcinoma and metastatic carcinoma) and a variety of solid tumors such as medullary thyroid carcin...